TK112690

· Tosk, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TK112690, covering 2023-08-14 to 2023-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690 [Phase 2]